The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Treatment strategies for patients with dysexecutive syndromes

Published Online:https://doi.org/10.1176/jnp.6.4.411

Patients with prefrontal behavioral syndromes (dysexecutive, disinhibited, and apathetic) present a significant therapeutic challenge that demands the integration of psychopharmacologic, behavioral, and systemic interventions. Unfortunately, the behavioral disturbances of such patients are frequently misinterpreted and therefore inadequately treated. This article describes the various strategies that are available to the clinician in treating patients with prefrontal deficits.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.